Clinical responses and persistent BRAF V600E+ blood cells in children with LCH treated with MAPK pathway inhibition-Reference-Cited by-同舟云学术

Clinical responses and persistent BRAF V600E+ blood cells in children with LCH treated with MAPK pathway inhibition

Published:2019-04-11 Issue:15 Volume:133 Page:1691-1694
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Eckstein Olive S.¹²^ORCID,Visser Johannes³,Rodriguez-Galindo Carlos⁴⁵,Allen Carl E.¹²,

Affiliation:

1. Texas Children’s Cancer and Hematology Centers, Texas Children’s Hospital, Houston, TX;

2. Division of Pediatric Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX;

3. Department of Paediatric Haematology and Oncology, Cambridge University Hospitals National Health Service Foundation Trust, Cambridge, United Kingdom; and

4. Department of Oncology and

5. Department of Global Pediatric Medicine, St Jude Children’s Research Hospital, Memphis, TN

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/133/15/1691/1553041/blood878363.pdf

Reference26 articles.

1. Langerhans-cell histiocytosis;Allen;N Engl J Med,2018

2. Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis;Gadner;Blood,2013

3. Permanent consequences in Langerhans cell histiocytosis patients: a pilot study from the Histiocyte Society-Late Effects Study Group;Haupt;Pediatr Blood Cancer,2004

4. Evaluation and treatment of Langerhans cell histiocytosis patients with central nervous system abnormalities: Current views and new vistas;Yeh;Pediatr Blood Cancer,2018

5. Recurrent BRAF mutations in Langerhans cell histiocytosis;Badalian-Very;Blood,2010

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world experience with targeted therapy in patients with histiocytic neoplasms in the Netherlands and in Belgium;Blood Neoplasia;2024-09

2. MEK Inhibition in the Treatment of Congenital Langerhans Cell Histiocytosis: A Case Report and Review of the Literature;Journal of Pediatric Hematology/Oncology;2024-08-05

3. Targeted Therapy With Vemurafenib in Brazilian Children With Refractory Langerhans Cell Histiocytosis: Two Case Reports and Review of Literature;Cancer Reports;2024-08

4. Refractory juvenile xanthogranuloma of the mastoid bone responsive to trametinib;Pediatric Blood & Cancer;2024-07-18

5. Orbital histiocytosis; From A to Z;International Ophthalmology;2024-06-20